Verrica Pharmaceuticals Inc. Basic Shares Outstanding (Weighted Average)
Verrica Pharmaceuticals Inc. (VRCA) reported Basic Shares Outstanding (Weighted Average) of 21.31 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-06
- Verrica Pharmaceuticals Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 21.31M shares, a 124.55% increase year-over-year.
- Verrica Pharmaceuticals Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 21.31M shares, a 124.65% increase year-over-year.
- Verrica Pharmaceuticals Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 14.14M shares, a 109.70% increase year-over-year.
- Verrica Pharmaceuticals Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 9.49M shares, a 102.76% increase year-over-year.
- Verrica Pharmaceuticals Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 10.65M shares, a 105.61% increase from fiscal 2024.
- Verrica Pharmaceuticals Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 5.18M shares, a 88.57% decline from fiscal 2023.
- Verrica Pharmaceuticals Inc. weighted average number of shares outstanding, basic for fiscal 2023 was 45.34M shares, a 32.72% increase from fiscal 2022.
- Verrica Pharmaceuticals Inc. weighted average number of shares outstanding, basic for fiscal 2022 was 34.16M shares, a 26.32% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month | Weighted Average Number of Shares Outstanding, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 21.31M shares 10-Q · filed 2026-08-06 | 21.31M shares 10-Q · filed 2026-08-06 | 18.92M shares derived: average of 3 quarters · filed 2026-08-06 | 16.56M shares derived: average of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | 21.31M shares 10-Q · filed 2026-05-12 | 17.72M shares derived: average of 2 quarters · filed 2026-05-12 | 14.98M shares derived: average of 3 quarters · filed 2026-05-12 | 13.61M shares derived: average of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | 14.14M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | 11.82M shares derived: average of 2 quarters · filed 2026-03-11 | 11.04M shares derived: average of 3 quarters · filed 2026-08-06 | 10.65M shares 10-K · filed 2026-03-11 | ||||
| 2025-09-30 | 9.49M shares 10-Q · filed 2025-11-14 | 9.49M shares derived: average of 2 quarters · filed 2026-08-06 | 9.49M shares 10-Q · filed 2025-11-14 | 8.80M shares derived: average of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | 9.49M shares 10-Q · filed 2026-08-06 | 9.49M shares 10-Q · filed 2026-08-06 | 8.57M shares derived: average of 3 quarters · filed 2026-08-06 | 7.60M shares derived: average of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | 9.48M shares 10-Q · filed 2026-05-12 | 94.84M shares 10-Q · filed 2025-05-13 | 8.11M shares derived: average of 2 quarters · filed 2026-05-12 | 6.97M shares derived: average of 3 quarters · filed 2026-05-12 | 6.39M shares derived: average of 4 quarters · filed 2026-05-12 | |||
| 2024-12-31 | 6.74M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | 5.71M shares derived: average of 2 quarters · filed 2026-03-11 | 5.36M shares derived: average of 3 quarters · filed 2026-03-11 | 5.18M shares 10-K · filed 2026-03-11 | 51.81M shares 10-K · filed 2025-03-11 | |||
| 2024-09-30 | 4.68M shares 10-Q · filed 2025-11-14 | 46.81M shares 10-Q · filed 2024-11-05 | 4.67M shares derived: average of 2 quarters · filed 2025-11-14 | 4.66M shares 10-Q · filed 2025-11-14 | 46.60M shares 10-Q · filed 2024-11-05 | 25.53M shares derived: average of 4 quarters · filed 2025-11-14 | ||
| 2024-06-30 | 4.65M shares 10-Q · filed 2025-08-12 | 46.50M shares 10-Q · filed 2024-08-14 | 4.65M shares 10-Q · filed 2025-08-12 | 46.49M shares 10-Q · filed 2024-08-14 | 32.49M shares derived: average of 3 quarters · filed 2025-08-12 | 35.88M shares derived: average of 4 quarters · filed 2025-08-12 | ||
| 2024-03-31 | 46.48M shares 10-Q · filed 2025-05-13 | 46.40M shares derived: average of 2 quarters · filed 2025-05-13 | 46.29M shares derived: average of 3 quarters · filed 2025-05-13 | 46.20M shares derived: average of 4 quarters · filed 2025-05-13 | ||||
| 2023-12-31 | 46.32M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | 46.20M shares derived: average of 2 quarters · filed 2025-03-11 | 46.10M shares derived: average of 3 quarters · filed 2025-03-11 | 45.34M shares 10-K · filed 2025-03-11 | ||||
| 2023-09-30 | 46.07M shares 10-Q · filed 2024-11-05 | 46.00M shares derived: average of 2 quarters · filed 2024-11-05 | 45.02M shares 10-Q · filed 2024-11-05 | 44.05M shares derived: average of 4 quarters · filed 2024-11-05 | ||||
| 2023-06-30 | 45.92M shares 10-Q · filed 2024-08-14 | 44.48M shares 10-Q · filed 2024-08-14 | 43.37M shares derived: average of 3 quarters · filed 2024-08-14 | 42.60M shares derived: average of 4 quarters · filed 2024-08-14 | ||||
| 2023-03-31 | 43.02M shares 10-Q · filed 2024-05-13 | 42.10M shares derived: average of 2 quarters · filed 2024-05-13 | 41.50M shares derived: average of 3 quarters · filed 2024-05-13 | 38.00M shares derived: average of 4 quarters · filed 2024-05-13 | ||||
| 2022-12-31 | 41.17M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | 40.74M shares derived: average of 2 quarters · filed 2024-02-29 | 36.33M shares derived: average of 3 quarters · filed 2024-02-29 | 34.16M shares 10-K · filed 2024-02-29 | ||||
| 2022-09-30 | 40.30M shares 10-Q · filed 2023-11-09 | 33.91M shares derived: average of 2 quarters · filed 2023-11-09 | 31.83M shares 10-Q · filed 2023-11-09 | 30.72M shares derived: average of 4 quarters · filed 2023-11-09 | ||||
| 2022-06-30 | 27.52M shares 10-Q · filed 2023-08-08 | 27.52M shares 10-Q · filed 2023-08-08 | 27.52M shares derived: average of 3 quarters · filed 2023-08-08 | 27.52M shares derived: average of 4 quarters · filed 2023-08-08 | ||||
| 2022-03-31 | 27.52M shares 10-Q · filed 2023-05-09 | 27.52M shares derived: average of 2 quarters · filed 2023-05-09 | 27.52M shares derived: average of 3 quarters · filed 2023-05-09 | 27.52M shares derived: average of 4 quarters · filed 2023-05-09 | ||||
| 2021-12-31 | 27.52M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | 27.52M shares derived: average of 2 quarters · filed 2023-03-06 | 27.52M shares derived: average of 3 quarters · filed 2023-03-06 | 27.04M shares 10-K · filed 2023-03-06 | ||||
| 2021-09-30 | 27.52M shares 10-Q · filed 2022-11-07 | 27.52M shares derived: average of 2 quarters · filed 2022-11-07 | 26.88M shares 10-Q · filed 2022-11-07 | |||||
| 2021-06-30 | 27.51M shares 10-Q · filed 2022-08-11 | 27.70M shares 10-Q · filed 2022-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |